Form 8-K - Current report:
SEC Accession No. 0001731122-22-001003
Filing Date
2022-05-26
Accepted
2022-05-26 12:00:25
Documents
13
Period of Report
2022-05-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e3799_8-k.htm   iXBRL 8-K 25994
2 EXHIBIT 99.1 e3799_ex99-1.htm EX-99.1 9695
  Complete submission text file 0001731122-22-001003.txt   209664

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE enob-20220525.xsd EX-101.SCH 2968
4 XBRL LABEL FILE enob-20220525_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE enob-20220525_pre.xml EX-101.PRE 22365
7 EXTRACTED XBRL INSTANCE DOCUMENT e3799_8-k_htm.xml XML 3500
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 22967297
SIC: 2834 Pharmaceutical Preparations